Activation of CD11b+ Kupffer Cells/Macrophages as a Common Cause for Exacerbation of TNF/Fas-Ligand-Dependent Hepatitis in Hypercholesterolemic Mice

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Nakashima, Hiroyuki ^a   Ogawa, Yoshiko ^a   Shono, Satoshi ^a   Kinoshita, Manabu ^a   Nakashima, Masahiro ^a   Sato, Atsushi ^a   Ikarashi, Masami ^a   Seki, Shuhji ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD11B ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; FAS LIGAND; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; TOLL LIKE RECEPTOR 9; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURFACE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; HEPATITIS; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; KUPFFER CELL; LIPID DIET; LIPID LIVER LEVEL; MACROPHAGE; MALE; MONONUCLEAR CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; T LYMPHOCYTE ACTIVATION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD11B; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CHOLESTEROL; DIET, HIGH-FAT; DRUG-INDUCED LIVER INJURY; FAS LIGAND PROTEIN; GALACTOSYLCERAMIDES; GENE EXPRESSION REGULATION; HYPERCHOLESTEROLEMIA; KILLER CELLS, NATURAL; KUPFFER CELLS; LIVER; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; OLIGODEOXYRIBONUCLEOTIDES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); MUS;

EID: 84872801313     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049339     Document Type: Article

References (37)

1. Bouwens L, Baekeland M, De Zanger R, Wisse E, (1986) Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver. Hepatology 6: 718-722.
2. Seki S, Habu Y, Kawamura T, Takeda K, Dobashi H, et al. (2000) The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol Rev 174: 35-46.
3. Doherty DG, O'Farrelly C, (2000) Innate and adaptive lymphoid cells in the human liver. Immunol Rev 174: 5-20.
4. Nakagawa R, Nagafune I, Tazunoki Y, Ehara H, Tomura H, et al. (2001) Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice. J Immunol 166: 6578-6584.
5. Inui T, Nakagawa R, Ohkura S, Habu Y, Koike Y, et al. (2002) Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro. J Immunol 169: 6127-6132.
6. Inatsu A, Kinoshita M, Nakashima H, Shimizu J, Saitoh D, et al. (2009) Novel mechanism of C-reactive protein for enhancing mouse liver innate immunity. Hepatology 49: 2044-2054.
7. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, et al. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546-549.
8. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
9. Kawabata T, Kinoshita M, Inatsu A, Habu Y, Nakashima H, et al. (2008) Functional alterations of liver innate immunity of mice with aging in response to CpG-oligodeoxynucleotide. Hepatology 48: 1586-1597.
10. Kinoshita M, Uchida T, Sato A, Nakashima M, Nakashima H, et al. (2010) Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice. J Hepatol 53: 903-910.
11. Klein I, Cornejo JC, Polakos NK, John B, Wuensch SA, et al. (2007) Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood 110: 4077-4085.
12. Holt MP, Cheng L, Ju C, (2008) Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J Leukoc Biol 84: 1410-1421.
13. Shono S, Habu Y, Nakashima M, Sato A, Nakashima H, et al. (2011) The immunologic outcome of enhanced function of mouse liver lymphocytes and kupffer cells by high-fat and high-cholesterol diet. Shock 36: 484-493.
14. Motoki K, Maeda K, Ueno H, Kobayashi E, Uchida T, et al. (1996) Antitumor activities of combined treatment with a novel immunomodulator, (2S,3S,4R)-1-O-(alpha-D-Galactopyranosyl)-2-(N-Hexacosanoylamino)-1,3,4- octadecanetriol (KRN7000), and radiotherapy in tumor-bearing mice. Oncol Res 8: 155-162.
15. Yamaguchi Y, Motoki K, Ueno H, Maeda K, Kobayashi E, et al. (1996) Enhancing effects of (2S,3S,4R)-1-O-(alpha-D-galactopyranosyl)-2-(N-hexacosanoylamino)-1,3,4-octadecanetriol (KRN7000) on antigen-presenting function of antigen-presenting cells and antimetastatic activity of KRN7000-pretreated antigen-presenting cells. Oncol Res 8: 399-407.
16. Inui T, Nakashima H, Habu Y, Nakagawa R, Fukasawa M, et al. (2005) Neutralization of tumor necrosis factor abrogates hepatic failure induced by alpha-galactosylceramide without attenuating its antitumor effect in aged mice. J Hepatol 43: 670-678.
17. Habu Y, Uchida T, Inui T, Nakashima H, Fukasawa M, et al. (2004) Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment. Immunology 113: 35-43.
18. Hong S, Scherer DC, Singh N, Mendiratta SK, Serizawa I, et al. (1999) Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. Immunol Rev 169: 31-44.
19. Fuji N, Ueda Y, Fujiwara H, Toh T, Yoshimura T, et al. (2000) Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver. Clin Cancer Res 6: 3380-3387.
20. Nakagawa R, Inui T, Nagafune I, Tazunoki Y, Motoki K, et al. (2004) Essential role of bystander cytotoxic CD122+CD8+ T cells for the antitumor immunity induced in the liver of mice by alpha-galactosylceramide. J Immunol 172: 6550-6557.
21. Krieg AM, (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20: 709-760.
22. Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, et al. (2009) Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50: 261-274.
23. Biburger M, Tiegs G, (2005) Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol 175: 1540-1550.
24. Libby P, (2002) Inflammation in atherosclerosis. Nature 420: 868-874.
25. Hansson GK, (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695.
26. Glass CK, Witztum JL, (2001) Atherosclerosis. the road ahead. Cell 104: 503-516.
27. Fischer B, von Knethen A, Brune B, (2002) Dualism of oxidized lipoproteins in provoking and attenuating the oxidative burst in macrophages: role of peroxisome proliferator-activated receptor-gamma. J Immunol 168: 2828-2834.
28. Nakai Y, Iwabuchi K, Fujii S, Ishimori N, Dashtsoodol N, et al. (2004) Natural killer T cells accelerate atherogenesis in mice. Blood 104: 2051-2059.
29. Tupin E, Nicoletti A, Elhage R, Rudling M, Ljunggren HG, et al. (2004) CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med 199: 417-422.
30. Farrell GC, Larter CZ, (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43: S99-S112.
31. Day CP, James OF, (1998) Steatohepatitis: a tale of two "hits"? Gastroenterology 114: 842-845.
32. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, et al. (2002) Mechanisms of hepatotoxicity. Toxicol Sci 65: 166-176.
33. Kawarabayashi N, Seki S, Hatsuse K, Ohkawa T, Koike Y, et al. (2000) Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 32: 962-969.
34. Seki S, Nakashima H, Nakashima M, Kinoshita M, (2011) Antitumor immunity produced by the liver Kupffer cells, NK cells, NKT cells, and CD8 CD122 T cells. Clin Dev Immunol 2011: 868345.
35. Takayama E, Koike Y, Ohkawa T, Majima T, Fukasawa M, et al. (2003) Functional and Vbeta repertoire characterization of human CD8+ T-cell subsets with natural killer cell markers, CD56+ CD57- T cells, CD56+ CD57+ T cells and CD56- CD57+ T cells. Immunology 108: 211-219.
36. Nakashima H, Inui T, Habu Y, Kinoshita M, Nagao S, et al. (2006) Activation of mouse natural killer T cells accelerates liver regeneration after partial hepatectomy. Gastroenterology 131: 1573-1583.
37. Schramm C, Schneider A, Marx A, Lohse AW, (2008) Adalimumab could suppress the activity of non alcoholic steatohepatitis (NASH). Z Gastroenterol 46: 1369-1371.